Read about Questcor Pharmaceuticals (QCOR)
here. The upcoming PDUFA for the company's infantile spasm drug, H.P Acthar Gel, is scheduled for Sept 11, 2010. The FDA requested an extension for reviewing this drug back in June which brought the shares down. However,
Questcor expressed confidence in gaining FDA nod for the drug in their
press release despite the delay. The positive sentiment will likely attract investors back ahead of the key decision date - Sept 11, 2010.
No comments:
Post a Comment